rs6180
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000163.5(GHR):āc.1630A>Cā(p.Ile544Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.447 in 1,613,300 control chromosomes in the GnomAD database, including 162,936 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.43 ( 14368 hom., cov: 32)
Exomes š: 0.45 ( 148568 hom. )
Consequence
GHR
NM_000163.5 missense
NM_000163.5 missense
Scores
1
5
12
Clinical Significance
Conservation
PhyloP100: 1.58
Genes affected
GHR (HGNC:4263): (growth hormone receptor) This gene encodes a member of the type I cytokine receptor family, which is a transmembrane receptor for growth hormone. Binding of growth hormone to the receptor leads to receptor dimerization and the activation of an intra- and intercellular signal transduction pathway leading to growth. Mutations in this gene have been associated with Laron syndrome, also known as the growth hormone insensitivity syndrome (GHIS), a disorder characterized by short stature. In humans and rabbits, but not rodents, growth hormone binding protein (GHBP) is generated by proteolytic cleavage of the extracellular ligand-binding domain from the mature growth hormone receptor protein. Multiple alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jun 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=1.2171396E-4).
BP6
Variant 5-42719137-A-C is Benign according to our data. Variant chr5-42719137-A-C is described in ClinVar as [Benign]. Clinvar id is 8658.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42719137-A-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.559 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GHR | NM_000163.5 | c.1630A>C | p.Ile544Leu | missense_variant | 10/10 | ENST00000230882.9 | NP_000154.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GHR | ENST00000230882.9 | c.1630A>C | p.Ile544Leu | missense_variant | 10/10 | 1 | NM_000163.5 | ENSP00000230882 | P1 |
Frequencies
GnomAD3 genomes AF: 0.431 AC: 65445AN: 151868Hom.: 14380 Cov.: 32
GnomAD3 genomes
AF:
AC:
65445
AN:
151868
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.436 AC: 109339AN: 250692Hom.: 24629 AF XY: 0.442 AC XY: 59947AN XY: 135484
GnomAD3 exomes
AF:
AC:
109339
AN:
250692
Hom.:
AF XY:
AC XY:
59947
AN XY:
135484
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.449 AC: 656062AN: 1461314Hom.: 148568 Cov.: 40 AF XY: 0.450 AC XY: 327308AN XY: 726956
GnomAD4 exome
AF:
AC:
656062
AN:
1461314
Hom.:
Cov.:
40
AF XY:
AC XY:
327308
AN XY:
726956
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.431 AC: 65438AN: 151986Hom.: 14368 Cov.: 32 AF XY: 0.431 AC XY: 31996AN XY: 74270
GnomAD4 genome
AF:
AC:
65438
AN:
151986
Hom.:
Cov.:
32
AF XY:
AC XY:
31996
AN XY:
74270
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1654
ALSPAC
AF:
AC:
1717
ESP6500AA
AF:
AC:
1714
ESP6500EA
AF:
AC:
3961
ExAC
AF:
AC:
53769
Asia WGS
AF:
AC:
1843
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:11Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 17, 2014 | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Laron-type isolated somatotropin defect Benign:3
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 29, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | This variant is associated with the following publications: (PMID: 17547682, 12910492, 27862957) - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Short stature due to partial GHR deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Hypercholesterolemia, familial, 1 Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Aug 30, 2003 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
T;T;.;T;T;T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
D
LIST_S2
Benign
.;.;T;.;.;T;.;T
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M;.;M;M;M;M;.
MutationTaster
Benign
P;P;P
PrimateAI
Benign
T
PROVEAN
Benign
N;.;.;.;.;.;.;N
REVEL
Benign
Sift
Uncertain
D;.;.;.;.;.;.;D
Sift4G
Benign
T;T;T;T;T;T;T;T
Polyphen
P;P;.;P;P;P;P;.
Vest4
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at